| For: | Martin G, Beck P, Sigalet D. Gut hormones, and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol 2006; 12(26): 4117-4129 [PMID: 16830359 DOI: 10.3748/wjg.v12.i26.4117] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4117.htm |
| Number | Citing Articles |
| 1 |
D.L. Sigalet. Advances in glucagon like peptide-2 therapy. physiology, current indications and future directions. Seminars in Pediatric Surgery 2018; 27(4) doi: 10.1053/j.sempedsurg.2018.07.008
|
| 2 |
Tristan Frau, Myriam El Khatib, Brune De Dreuille, Lore Billiauws, Alexandre Nuzzo, Francisca Joly. Emerging drugs for the treatment of short bowel syndrome. Expert Opinion on Emerging Drugs 2024; 29(3) doi: 10.1080/14728214.2024.2357567
|
| 3 |
Munir Alamo, Matías Sepúlveda, José Gellona, Mauricio Herrera, Cristián Astorga, Carlos Manterola. Sleeve Gastrectomy with Jejunal Bypass for the Treatment of Type 2 Diabetes Mellitus in Patients with Body Mass Index <35 kg/m2. A cohort study. Obesity Surgery 2012; 22(7) doi: 10.1007/s11695-012-0652-x
|
| 4 |
Mina Rasouli, Sakineh Abbasi, Kazhal Sarsaifi, Homayoun Hani, Zalinah Ahmad, Abdul Rahman Omar. The L-Cell Isolation from Heterogonous Population of Intestinal Cell Line Using Antibiotic Selection Method. Applied Biochemistry and Biotechnology 2014; 172(1) doi: 10.1007/s12010-013-0514-6
|
| 5 |
Ryo Sueyoshi, Matthew W. Ralls, Daniel H. Teitelbaum. Glucagon-like peptide 2 increases efficacy of distraction enterogenesis. Journal of Surgical Research 2013; 184(1) doi: 10.1016/j.jss.2013.03.089
|
| 6 |
Roger Atanga, Varsha Singh, Julie G. In. Intestinal Enteroendocrine Cells: Present and Future Druggable Targets. International Journal of Molecular Sciences 2023; 24(10) doi: 10.3390/ijms24108836
|
| 7 |
Erik Näslund, Per M. Hellström. Drug targets modulating the gut-appetite-metabolism axis. Drug Discovery Today: Therapeutic Strategies 2007; 4(3) doi: 10.1016/j.ddstr.2007.10.008
|
| 8 |
Xiaogan Wang, Hao Chen, Shuangshuang Han, Lingbo Li, Hongjin Chen, Bolin Yang. The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1404658
|
| 9 |
Christine S. Van Der Werf, Tara D. Wabbersen, Nai–Hua Hsiao, Joana Paredes, Heather C. Etchevers, Peter M. Kroisel, Dick Tibboel, Candice Babarit, Richard A. Schreiber, Edward J. Hoffenberg, Michel Vekemans, Sirkka L. Zeder, Isabella Ceccherini, Stanislas Lyonnet, Ana S. Ribeiro, Raquel Seruca, Gerard J. te Meerman, Sven C.D. van Ijzendoorn, Iain T. Shepherd, Joke B.G.M. Verheij, Robert M.W. Hofstra. CLMP Is Required for Intestinal Development, and Loss-of-Function Mutations Cause Congenital Short-Bowel Syndrome. Gastroenterology 2012; 142(3) doi: 10.1053/j.gastro.2011.11.038
|
| 10 |
J.M. Morán Penco, M.I. Correa Antúnez, J.L. Amaya Lozano, A. Leal Macho, Jesus Salas Martinez, V. Climent. Changes in bile composition and liver ultrastructure after TPN alone and TPN with ultra-short bowel syndrome. e-SPEN Journal 2012; 7(2) doi: 10.1016/j.eclnm.2011.12.005
|
| 11 |
Tatsuru Kaji, Hiroaki Tanaka, Jens J. Holst, Heather Redstone, Laurie Wallace, Elaine de Heuval, David L. Sigalet. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat. European Journal of Pharmacology 2008; 596(1-3) doi: 10.1016/j.ejphar.2008.07.070
|
| 12 |
Cassandra A. Cairns, Lan Xiao, Jian-Ying Wang. Posttranscriptional Regulation of Intestinal Mucosal Growth and Adaptation by Noncoding RNAs in Critical Surgical Disorders. Journal of Investigative Surgery 2024; 37(1) doi: 10.1080/08941939.2024.2308809
|
| 13 |
David L. Sigalet, Mary E. Brindle, Dana Boctor, Bryan Dicken, Viona Lam, Lily Sia Lu, Elaine de Heuvel, Bolette Hartmann, Jens J. Holst. A safety and pharmacokinetic dosing study of glucagon-like peptide 2 in infants with intestinal failure. Journal of Pediatric Surgery 2017; 52(5) doi: 10.1016/j.jpedsurg.2017.01.034
|
| 14 |
Houssam E Mardini, Willem JS de Villiers. Teduglutide in intestinal adaptation and repair: light at the end of the tunnel. Expert Opinion on Investigational Drugs 2008; 17(6) doi: 10.1517/13543784.17.6.945
|
| 15 |
Emir Q. Haxhija, Hua Yang, Ariel U. Spencer, Hiroyuki Koga, Xiaoyi Sun, Daniel H. Teitelbaum. Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 295(1) doi: 10.1152/ajpgi.00589.2007
|
| 16 |
Hubert Zatorski, Maciej Sałaga, Jakub Fichna. Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives. Naunyn-Schmiedeberg's Archives of Pharmacology 2019; 392(11) doi: 10.1007/s00210-019-01698-z
|
| 17 |
Manabu Okawada, Jens J. Holst, Daniel H. Teitelbaum. Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome. Surgery 2011; 150(2) doi: 10.1016/j.surg.2011.05.013
|
| 18 |
Ulrich-Frank Pape, Sebastian Maasberg, Andreas Pascher. Pharmacological strategies to enhance adaptation in intestinal failure. Current Opinion in Organ Transplantation 2016; 21(2) doi: 10.1097/MOT.0000000000000296
|
| 19 |
Marli A. Robertson, David L. Sigalet, Jens J. Holst, Jon B. Meddings, Julie Wood, Keith A. Sharkey. Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study. Journal of Autism and Developmental Disorders 2008; 38(6) doi: 10.1007/s10803-007-0482-1
|
| 20 |
Sophie Pevny, Sebastian Maasberg, Anja Rieger, Mirjam Karber, Elisabeth Blüthner, Barbora Knappe-Drzikova, Dana Thurmann, Janine Büttner, Karsten-Henrich Weylandt, Bertram Wiedenmann, Verena Alexandra Müller, Hendrik Bläker, Andreas Pascher, Ulrich-Frank Pape. Experience with teduglutide treatment for short bowel syndrome in clinical practice. Clinical Nutrition 2019; 38(4) doi: 10.1016/j.clnu.2018.07.030
|
| 21 |
Gordon W. Moran, Joanne Pennock, John T. McLaughlin. Enteroendocrine cells in terminal ileal Crohn's disease. Journal of Crohn's and Colitis 2012; 6(9) doi: 10.1016/j.crohns.2012.01.013
|
| 22 |
Hans-Rudolf Berthoud, Andrew C. Shin, Huiyuan Zheng. Obesity surgery and gut–brain communication. Physiology & Behavior 2011; 105(1) doi: 10.1016/j.physbeh.2011.01.023
|
| 23 |
Jun Chen, Jia-Tian Dong, Xiao-Jing Li, Ye Gu, Zhi-Jian Cheng, Yuan-Kun Cai. Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats. World Journal of Gastroenterology 2015; 21(2): 484-490 doi: 10.3748/wjg.v21.i2.484
|
| 24 |
Jacqueline J. Wessel, Samuel A. Kocoshis. Nutritional Management of Infants with Short Bowel Syndrome. Seminars in Perinatology 2007; 31(2) doi: 10.1053/j.semperi.2007.02.009
|
| 25 |
D. L. Sigalet. NONRUMINANT NUTRITION SYMPOSIUM: The role of glucagon-like peptide-2 in controlling intestinal function in human infants: Regulator or bystander?1,2,3. Journal of Animal Science 2012; 90(4) doi: 10.2527/jas.2011-4704
|
| 26 |
David L. Sigalet, Viona Lam, Mary Brindle, Dana Boctor, Laurie Wallace, Elaine de Heuval, Bollette Hartmann, Jens J. Holst. The glucagon like peptide-2 ‘axis’: Capacity for production and response following intestinal resection or repair of gastroschisis in infants. Journal of Pediatric Surgery 2018; 53(5) doi: 10.1016/j.jpedsurg.2018.02.012
|
| 27 |
Hector Solar, Mariana Doeyo, Mariana Ortega, Silvia De Barrio, Estela Olano, Eduardo Moreira, Martin Buncuga, Alejandra Manzur, Adriana Crivelli, Gabriel Gondolesi. Postsurgical Intestinal Rehabilitation Using Semisynthetic Glucagon‐Like Peptide‐2 Analogue (sGLP‐2) at a Referral Center: Can Patients Achieve Parenteral Nutrition and sGLP‐2 Independency?. Journal of Parenteral and Enteral Nutrition 2021; 45(5) doi: 10.1002/jpen.1983
|
| 28 |
George Biouss, Carol Lee, Bo Li, Khosrow Adeli, Agostino Pierro. Glucagon-like peptides agonists promote maturation of intestinal organoids derived from neonates with necrotizing enterocolitis. Pediatric Surgery International 2025; 41(1) doi: 10.1007/s00383-024-05957-w
|
| 29 |
Harish Amin, Jens J. Holst, Bolette Hartmann, Laurie Wallace, Jim Wright, David L. Sigalet. Functional Ontogeny of the Proglucagon-Derived Peptide Axis in the Premature Human Neonate. Pediatrics 2008; 121(1) doi: 10.1542/peds.2007-1461
|
| 30 |
Gordon W. Moran, Fiona C. Leslie, Scott E. Levison, John T. McLaughlin. Review: Enteroendocrine cells: Neglected players in gastrointestinal disorders?. Therapeutic Advances in Gastroenterology 2008; 1(1) doi: 10.1177/1756283X08093943
|
| 31 |
Lore Billiauws, Olivier Corcos, Francisca Joly. What's new in short bowel syndrome?. Current Opinion in Clinical Nutrition & Metabolic Care 2018; 21(4) doi: 10.1097/MCO.0000000000000473
|
| 32 |
Flavia Prodam, Simonetta Bellone, Silvia Savastio, Arianna Busti, Carla Guidi, Alice Monzani, Gianni Bona. Neonatology. 2012; doi: 10.1007/978-88-470-1405-3_43
|
| 33 |
David L. Sigalet, Mary Brindle, Dana Boctor, Linda Casey, Bryan Dicken, Sonia Butterworth, Viona Lam, Vikram Karnik, Elaine de Heuvel, Bolette Hartmann, Jens Holst. Safety and Dosing Study of Glucagon‐Like Peptide 2 in Children With Intestinal Failure. Journal of Parenteral and Enteral Nutrition 2017; 41(5) doi: 10.1177/0148607115609566
|
| 34 |
Jean‐Francois Marier, Mohamad‐Samer Mouksassi, Nathalie H. Gosselin, Martin Beliveau, Jane Cyran, John Wallens. Population Pharmacokinetics of Teduglutide Following Repeated Subcutanenous Administrations in Healthy Participants and in Patients With Short Bowel Syndrome and Crohn's Disease. The Journal of Clinical Pharmacology 2010; 50(1) doi: 10.1177/0091270009342252
|
| 35 |
Tatsuru Kaji, Hiroaki Tanaka, Heather Redstone, Laurie E. Wallace, Jens J. Holst, David L. Sigalet. Temporal Changes in the Intestinal Growth Promoting Effects of Glucagon-Like Peptide 2 Following Intestinal Resection. Journal of Surgical Research 2009; 152(2) doi: 10.1016/j.jss.2008.05.007
|
| 36 |
Michael B. Mumphrey, Zheng Hao, R. Leigh Townsend, Laurel M. Patterson, Hans-Rudolf Berthoud. Sleeve Gastrectomy Does Not Cause Hypertrophy and Reprogramming of Intestinal Glucose Metabolism in Rats. Obesity Surgery 2015; 25(8) doi: 10.1007/s11695-014-1547-9
|
| 37 |
Lore Billiauws, Julie Bataille, Vanessa Boehm, Olivier Corcos, Francisca Joly. Teduglutide for treatment of adult patients with short bowel syndrome. Expert Opinion on Biological Therapy 2017; 17(5) doi: 10.1080/14712598.2017.1304912
|
| 38 |
G.W. Moran, C. O'Neill, J.T. McLaughlin. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier. Regulatory Peptides 2012; 178(1-3) doi: 10.1016/j.regpep.2012.07.002
|
| 39 |
Vance L. Albaugh, Yanlin He, Heike Münzberg, Christopher D. Morrison, Sangho Yu, Hans-Rudolf Berthoud. Regulation of body weight: Lessons learned from bariatric surgery. Molecular Metabolism 2023; 68 doi: 10.1016/j.molmet.2022.101517
|
| 40 |
Ruben Vaidya, Joe X. Yi, T. Michael O’Shea, Elizabeth T. Jensen, Robert M. Joseph, Jeffrey Shenberger, Semsa Gogcu, Kathryn Wagner, Michael E. Msall, Amanda L. Thompson, Jean A. Frazier, Rebecca Fry, Rachana Singh. Long-Term Outcome of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation. Pediatrics 2022; 150(5) doi: 10.1542/peds.2022-056445
|
| 41 |
Joseph J. Lee, Pratikiran Bajgain, Amy L. Lightner. GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity. Frontiers in Gastroenterology 2026; 5 doi: 10.3389/fgstr.2026.1790420
|
| 42 |
Annika Mutanen, Mikko P. Pakarinen. Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure. Clinical Nutrition 2017; 36(5) doi: 10.1016/j.clnu.2016.09.002
|
| 43 |
Tsuyoshi Sakurai, Hironori Kudo, Nakamura Megumi, Ryo Ando, Takuro Kazama, Ryuji Okubo, Masatoshi Hashimoto, Ko Minoshima, Motoshi Wada. A case report on the long‐term use of teduglutide in a pediatric patient with short bowel syndrome. Nutrition in Clinical Practice 2025; doi: 10.1002/ncp.70023
|
| 44 |
David L. Sigalet, Laurie E. Wallace, Jens J. Holst, Gary R. Martin, Tatsuru Kaji, Hiroaki Tanaka, Keith A. Sharkey. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007; 293(1) doi: 10.1152/ajpgi.00530.2006
|
| 45 |
Kazuhiko Nakame, Tatsuru Kaji, Motoi Mukai, Shin Shinyama, Hiroshi Matsufuji. The protective and anti-inflammatory effects of glucagon-like peptide-2 in an experimental rat model of necrotizing enterocolitis. Peptides 2016; 75 doi: 10.1016/j.peptides.2015.07.025
|
| 46 |
Ryo Sueyoshi, Kathleen M. Woods Ignatoski, Manabu Okawada, Bolette Hartmann, Jens Holst, Daniel H. Teitelbaum. Stimulation of intestinal growth and function with DPP4 inhibition in a mouse short bowel syndrome model. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 307(4) doi: 10.1152/ajpgi.00363.2013
|
| 47 |
Laura Gillard, Lore Billiauws, Bogdan Stan-Iuga, Lara Ribeiro-Parenti, Anne-Charlotte Jarry, Jean-Baptiste Cavin, Françoise Cluzeaud, Camille Mayeur, Muriel Thomas, Jean-Noël Freund, Jean-Marc Lacorte, Maude Le Gall, André Bado, Francisca Joly, Johanne Le Beyec. Enhanced Ghrelin Levels and Hypothalamic Orexigenic AgRP and NPY Neuropeptide Expression in Models of Jejuno-Colonic Short Bowel Syndrome. Scientific Reports 2016; 6(1) doi: 10.1038/srep28345
|
| 48 |
Meredith C. Hitch, Jennifer A. Leinicke, Derek Wakeman, Jun Guo, Chris R. Erwin, Kathryn J. Rowland, Ellen C. Merrick, Robert O. Heuckeroth, Brad W. Warner. Ret heterozygous mice have enhanced intestinal adaptation after massive small bowel resection. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(10) doi: 10.1152/ajpgi.00296.2011
|
| 49 |
Maria C Riutort, Gigliola Alberti, Juan Cristóbal Gana, Luis A Villarroel del Pino, Lorena I Cifuentes, Marcela Rivera-Cornejo. Teduglutide for the treatment of patients with short bowel syndrome. Cochrane Database of Systematic Reviews 2021; 2021(7) doi: 10.1002/14651858.CD014216
|
| 50 |
Michael E. Höllwarth.
Short Bowel Syndrome in Childhood
. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2014; 6(2) doi: 10.4199/C00104ED1V01Y201402ISP050
|
| 51 |
Galina Sanaksenaho, Annika Mutanen, Antti I. Koivusalo, Laura Merras‐Salmio, Mikko P. Pakarinen. Duodenal Disaccharidase Activities During and After Weaning off Parenteral Nutrition in Pediatric Intestinal Failure. Journal of Pediatric Gastroenterology and Nutrition 2017; 64(5) doi: 10.1097/MPG.0000000000001347
|
| 52 |
Kalyana C. Venneti, Chandralal M. Hewage. Conformational and molecular interaction studies of glucagon-like peptide-2 with its N-terminal extracellular receptor domain. FEBS Letters 2011; 585(2) doi: 10.1016/j.febslet.2010.12.011
|
| 53 |
M S Mouksassi, J F Marier, J Cyran, A A Vinks. Clinical Trial Simulations in Pediatric Patients Using Realistic Covariates: Application to Teduglutide, a Glucagon-Like Peptide-2 Analog in Neonates and Infants With Short-Bowel Syndrome. Clinical Pharmacology & Therapeutics 2009; 86(6) doi: 10.1038/clpt.2009.199
|
| 54 |
Xiaoling Jin, Teresa A Zimmers, Zongxiu Zhang, Robert H Pierce, Leonidas G Koniaris. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 2010; 59(2) doi: 10.1136/gut.2008.151175
|
| 55 |
Michelle Cronin, Marco Ventura, Gerald F. Fitzgerald, Douwe van Sinderen. Progress in genomics, metabolism and biotechnology of bifidobacteria. International Journal of Food Microbiology 2011; 149(1) doi: 10.1016/j.ijfoodmicro.2011.01.019
|
| 56 |
Manabu Okawada, Haytham Mustafa Maria, Daniel H. Teitelbaum. Distraction Induced Enterogenesis: A Unique Mouse Model Using Polyethylene Glycol. Journal of Surgical Research 2011; 170(1) doi: 10.1016/j.jss.2011.03.041
|
| 57 |
G.W. Moran, C. O'Neill, P. Padfield, J.T. McLaughlin. Dipeptidyl peptidase-4 expression is reduced in Crohn's disease. Regulatory Peptides 2012; 177(1-3) doi: 10.1016/j.regpep.2012.04.006
|
| 58 |
|
| 59 |
Flavia Prodam, Simonetta Bellone, Roberta Ricotti, Alice Monzani, Giulia Genoni, Enza Giglione, Gianni Bona. Neonatology. 2018; doi: 10.1007/978-3-319-29489-6_184
|
| 60 |
Hamdy Khaled Sabra, Gehad S. Remeih, Ibraheem M. Kereet, Mohammad Hamad, Yassmien Ali Ahmed, Kainat Jahangir, Mostafa Abdulraheem Bakr, Fatma Assad Alagelli, Hadeer Sherif, Mohamed Elsaid. Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis. Journal of Gastrointestinal Surgery 2024; 28(7) doi: 10.1016/j.gassur.2024.04.009
|
| 61 |
Jean‐Francois Marier, Martin Beliveau, Mohamad‐Samer Mouksassi, Paula Shaw, Jane Cyran, Jothi Kesavan, John Wallens, Hamim Zahir, David Wells, John Caminis. Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon‐Like Peptide‐2 (GLP‐2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects. The Journal of Clinical Pharmacology 2008; 48(11) doi: 10.1177/0091270008320605
|
| 62 |
Flavia Prodam, Simonetta Bellone, Roberta Ricotti, Alice Monzani, Giulia Genoni, Enza Giglione, Gianni Bona. Neonatology. 2016; doi: 10.1007/978-3-319-18159-2_184-1
|
| 63 |
Jessie A. Elliott, John V. Reynolds, Carel W. le Roux, Neil G. Docherty. Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake. Expert Review of Endocrinology & Metabolism 2016; 11(6) doi: 10.1080/17446651.2016.1245140
|
| 64 |
Catherine P. A. Ivory, Laurie E. Wallace, Donna-Marie McCafferty, David L. Sigalet. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 295(6) doi: 10.1152/ajpgi.90494.2008
|
| 65 |
E.P. Misiakos, G. Agrogiannis, P. Patapis, I. Dontas, K. Petropoulos, N. Machairas, E. Giamarellos-Bourboulis”, T. Liakakos, A. Machairas. Expression of Tissue IGF 1, TGFß and EGFR in the Sequential Steps of Intestinal Adaptation in a Rat Model of Short Bowel Syndrome. Acta Chirurgica Belgica 2013; 113(2) doi: 10.1080/00015458.2013.11680898
|